These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 19148581

  • 61. TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells.
    Uno K, Inukai T, Kayagaki N, Goi K, Sato H, Nemoto A, Takahashi K, Kagami K, Yamaguchi N, Yagita H, Okumura K, Koyama-Okazaki T, Suzuki T, Sugita K, Nakazawa S.
    Blood; 2003 May 01; 101(9):3658-67. PubMed ID: 12506034
    [Abstract] [Full Text] [Related]

  • 62. Suberoylanilide hydroxamic acid sensitizes human oral cancer cells to TRAIL-induced apoptosis through increase DR5 expression.
    Yeh CC, Deng YT, Sha DY, Hsiao M, Kuo MY.
    Mol Cancer Ther; 2009 Sep 01; 8(9):2718-25. PubMed ID: 19737941
    [Abstract] [Full Text] [Related]

  • 63. Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells.
    Nakata S, Yoshida T, Horinaka M, Shiraishi T, Wakada M, Sakai T.
    Oncogene; 2004 Aug 19; 23(37):6261-71. PubMed ID: 15208660
    [Abstract] [Full Text] [Related]

  • 64. Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle.
    Ren YG, Wagner KW, Knee DA, Aza-Blanc P, Nasoff M, Deveraux QL.
    Mol Biol Cell; 2004 Nov 19; 15(11):5064-74. PubMed ID: 15356269
    [Abstract] [Full Text] [Related]

  • 65. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
    Poulaki V, Mitsiades CS, McMullan C, Fanourakis G, Negri J, Goudopoulou A, Halikias IX, Voutsinas G, Tseleni-Balafouta S, Miller JW, Mitsiades N.
    Invest Ophthalmol Vis Sci; 2005 Jan 19; 46(1):358-66. PubMed ID: 15623796
    [Abstract] [Full Text] [Related]

  • 66. TRAIL-induced apoptosis and expression of death receptor TRAIL-R1 and TRAIL-R2 in bladder cancer cells.
    Szliszka E, Mazur B, Zydowicz G, Czuba ZP, Król W.
    Folia Histochem Cytobiol; 2009 Jan 19; 47(4):579-85. PubMed ID: 20430723
    [Abstract] [Full Text] [Related]

  • 67. Regulation of TRAIL receptor expression by β-catenin in colorectal tumours.
    Jalving M, Heijink DM, Koornstra JJ, Boersma-van Ek W, Zwart N, Wesseling J, Sluiter WJ, de Vries EG, Kleibeuker JH, de Jong S.
    Carcinogenesis; 2014 May 19; 35(5):1092-9. PubMed ID: 24379239
    [Abstract] [Full Text] [Related]

  • 68. Constitutive localization of DR4 in lipid rafts is mandatory for TRAIL-induced apoptosis in B-cell hematologic malignancies.
    Marconi M, Ascione B, Ciarlo L, Vona R, Garofalo T, Sorice M, Gianni AM, Locatelli SL, Carlo-Stella C, Malorni W, Matarrese P.
    Cell Death Dis; 2013 Oct 17; 4(10):e863. PubMed ID: 24136227
    [Abstract] [Full Text] [Related]

  • 69. Caudatin potentiates the anti-tumor effects of TRAIL against human breast cancer by upregulating DR5.
    Fei HR, Yuan C, Wang GL, Zhao Y, Li ZJ, Du X, Wang FZ.
    Phytomedicine; 2019 Sep 17; 62():152950. PubMed ID: 31102888
    [Abstract] [Full Text] [Related]

  • 70. Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells.
    Guo F, Sigua C, Tao J, Bali P, George P, Li Y, Wittmann S, Moscinski L, Atadja P, Bhalla K.
    Cancer Res; 2004 Apr 01; 64(7):2580-9. PubMed ID: 15059915
    [Abstract] [Full Text] [Related]

  • 71. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.
    Evdokiou A, Bouralexis S, Atkins GJ, Chai F, Hay S, Clayer M, Findlay DM.
    Int J Cancer; 2002 Jun 01; 99(4):491-504. PubMed ID: 11992538
    [Abstract] [Full Text] [Related]

  • 72. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
    Kim SY, Hong M, Heo SH, Park S, Kwon TK, Sung YH, Oh Y, Lee S, Yi GS, Kim I.
    Mol Carcinog; 2018 Nov 01; 57(11):1492-1506. PubMed ID: 29964331
    [Abstract] [Full Text] [Related]

  • 73. [Mechanism of leukemia cell apoptosis induced by sodium butyrate activating TRAIL pathway].
    DU ZH, Ma KW, Yang GZ, Li W.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr 01; 17(2):315-8. PubMed ID: 19379558
    [Abstract] [Full Text] [Related]

  • 74. Dual Agonist Surrobody Simultaneously Activates Death Receptors DR4 and DR5 to Induce Cancer Cell Death.
    Milutinovic S, Kashyap AK, Yanagi T, Wimer C, Zhou S, O'Neil R, Kurtzman AL, Faynboym A, Xu L, Hannum CH, Diaz PW, Matsuzawa S, Horowitz M, Horowitz L, Bhatt RR, Reed JC.
    Mol Cancer Ther; 2016 Jan 01; 15(1):114-24. PubMed ID: 26516157
    [Abstract] [Full Text] [Related]

  • 75. Evaluating the effect of therapeutic stem cells on TRAIL resistant and sensitive medulloblastomas.
    Nesterenko I, Wanningen S, Bagci-Onder T, Anderegg M, Shah K.
    PLoS One; 2012 Jan 01; 7(11):e49219. PubMed ID: 23145127
    [Abstract] [Full Text] [Related]

  • 76. TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor.
    Nahacka Z, Svadlenka J, Peterka M, Ksandrova M, Benesova S, Neuzil J, Andera L.
    Biochim Biophys Acta Mol Cell Res; 2018 Mar 01; 1865(3):522-531. PubMed ID: 29278689
    [Abstract] [Full Text] [Related]

  • 77. Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and 5.
    Di X, Zhang G, Zhang Y, Takeda K, Rivera Rosado LA, Zhang B.
    Oncotarget; 2013 Sep 01; 4(9):1349-64. PubMed ID: 23988408
    [Abstract] [Full Text] [Related]

  • 78. Tanshinone IIA sensitizes TRAIL-induced apoptosis in glioblastoma through inducing the expression of death receptors (and suppressing STAT3 activation).
    Zhou X, Lv L, Tan Y, Zhang Z, Wei S, Xiao S.
    Brain Res; 2021 Sep 01; 1766():147515. PubMed ID: 33984327
    [Abstract] [Full Text] [Related]

  • 79. A functional, new short isoform of death receptor 4 in Ewing's sarcoma cell lines may be involved in TRAIL sensitivity/resistance mechanisms.
    Picarda G, Surget S, Guiho R, Téletchéa S, Berreur M, Tirode F, Pellat-Deceunynck C, Heymann D, Trichet V, Rédini F.
    Mol Cancer Res; 2012 Mar 01; 10(3):336-46. PubMed ID: 22258765
    [Abstract] [Full Text] [Related]

  • 80. AXL mediates TRAIL resistance in esophageal adenocarcinoma.
    Hong J, Belkhiri A.
    Neoplasia; 2013 Mar 01; 15(3):296-304. PubMed ID: 23479507
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.